Literature DB >> 29701781

Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer's disease.

P Hemachandra Reddy1,2,3,4,5,6,7, XiangLing Yin1, Maria Manczak1, Subodh Kumar1, Jangampalli Adi Pradeepkiran1, Murali Vijayan1, Arubala P Reddy1,8.   

Abstract

The purpose of our study was to determine the toxic effects of hippocampal mutant APP (mAPP) and amyloid beta (Aβ) in human mAPP complementary DNA (cDNA) transfected with primary mouse hippocampal neurons (HT22). Hippocampal tissues are the best source of studying learning and memory functions in patients with Alzheimer's disease (AD) and healthy controls. However, investigating immortalized hippocampal neurons that express AD proteins provide an excellent opportunity for drug testing. Using quantitative reverse transcriptase-polymerase chain reaction, immunoblotting & immunofluorescence and transmission electron microscopy, we assessed messenger RNA (mRNA) and protein levels of synaptic, autophagy, mitophagy, mitochondrial dynamics, biogenesis, dendritic protein MAP2 and assessed mitochondrial number and length in mAPP-HT22 cells that express Swedish/Indiana mutations. Mitochondrial function was assessed by measuring the levels of hydrogen peroxide, lipid peroxidation, cytochrome c oxidase activity and mitochondrial adenosine triphosphate. Increased levels of mRNA and protein levels of mitochondrial fission genes, Drp1 and Fis1 and decreased levels fusion (Mfn1, Mfn2 and Opa1) biogenesis (PGC1α, NRF1, NRF2 & TFAM), autophagy (ATG5 & LC3BI, LC3BII), mitophagy (PINK1 & TERT, BCL2 & BNIPBL), synaptic (synaptophysin & PSD95) and dendritic (MAP2) genes were found in mAPP-HT22 cells relative to WT-HT22 cells. Cell survival was significantly reduced mAPP-HT22 cells. GTPase-Drp1 enzymatic activity was increased in mAPP-HT22 cells. Transmission electron microscopy revealed significantly increased mitochondrial numbers and reduced mitochondrial length in mAPP-HT22 cells. These findings suggest that hippocampal accumulation of mAPP and Aβ is responsible for abnormal mitochondrial dynamics and defective biogenesis, reduced MAP2, autophagy, mitophagy and synaptic proteins & reduced dendritic spines and mitochondrial structural and functional changes in mAPP hippocampal cells. These observations strongly suggest that accumulation of mAPP and Aβ causes mitochondrial, synaptic and autophagy/mitophagy abnormalities in hippocampal neurons, leading to neuronal dysfunction.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29701781      PMCID: PMC6031001          DOI: 10.1093/hmg/ddy154

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  31 in total

1.  Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections.

Authors:  H Braak; E Braak
Journal:  Brain Pathol       Date:  1991-04       Impact factor: 6.508

Review 2.  Inflammation, autotoxicity and Alzheimer disease.

Authors:  P L McGeer; E G McGeer
Journal:  Neurobiol Aging       Date:  2001 Nov-Dec       Impact factor: 4.673

3.  Hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of Alzheimer's disease.

Authors:  Maria Manczak; Ramesh Kandimalla; Xiangling Yin; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2018-04-15       Impact factor: 6.150

4.  Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease.

Authors:  Marcus J Calkins; Maria Manczak; Peizhong Mao; Ulziibat Shirendeb; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2011-08-25       Impact factor: 6.150

5.  Are spatial memories strengthened in the human hippocampus during slow wave sleep?

Authors:  Philippe Peigneux; Steven Laureys; Sonia Fuchs; Fabienne Collette; Fabien Perrin; Jean Reggers; Christophe Phillips; Christian Degueldre; Guy Del Fiore; Joël Aerts; André Luxen; Pierre Maquet
Journal:  Neuron       Date:  2004-10-28       Impact factor: 17.173

6.  Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model.

Authors:  Heng Du; Lan Guo; Shiqiang Yan; Alexander A Sosunov; Guy M McKhann; Shirley ShiDu Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

7.  PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.

Authors:  Weiping Qin; Vahram Haroutunian; Pavel Katsel; Christopher P Cardozo; Lap Ho; Joseph D Buxbaum; Giulio M Pasinetti
Journal:  Arch Neurol       Date:  2009-03

8.  Induction and expression of long- and short-term neurosecretory potentiation in a neural cell line.

Authors:  B H Morimoto; D E Koshland
Journal:  Neuron       Date:  1990-12       Impact factor: 17.173

Review 9.  Intracellular amyloid-beta in Alzheimer's disease.

Authors:  Frank M LaFerla; Kim N Green; Salvatore Oddo
Journal:  Nat Rev Neurosci       Date:  2007-07       Impact factor: 34.870

10.  Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line.

Authors:  J B Davis; P Maher
Journal:  Brain Res       Date:  1994-07-25       Impact factor: 3.252

View more
  68 in total

1.  Mitophagy regulates integrity of mitochondria at synapses and is critical for synaptic maintenance.

Authors:  Sinsuk Han; Yu Young Jeong; Preethi Sheshadri; Xiao Su; Qian Cai
Journal:  EMBO Rep       Date:  2020-07-06       Impact factor: 8.807

Review 2.  Biological Functions of Autophagy Genes: A Disease Perspective.

Authors:  Beth Levine; Guido Kroemer
Journal:  Cell       Date:  2019-01-10       Impact factor: 41.582

3.  PINK1 Silencing Modifies Dendritic Spine Dynamics of Mouse Hippocampal Neurons.

Authors:  C J Hernández; C Báez-Becerra; M J Contreras-Zárate; H Arboleda; G Arboleda
Journal:  J Mol Neurosci       Date:  2019-09-05       Impact factor: 3.444

4.  Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease.

Authors:  Subodh Kumar; Arubala P Reddy; Xiangling Yin; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-06-08       Impact factor: 5.187

5.  AVP(4-8) Improves Cognitive Behaviors and Hippocampal Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease.

Authors:  Xiumin Zhang; Fang Zhao; Chenfang Wang; Jun Zhang; Yu Bai; Fang Zhou; Zhaojun Wang; Meina Wu; Wei Yang; Junhong Guo; Jinshun Qi
Journal:  Neurosci Bull       Date:  2019-10-12       Impact factor: 5.203

Review 6.  Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics.

Authors:  Neha Sawant; Hallie Morton; Sudhir Kshirsagar; Arubala P Reddy; P Hemachandra Reddy
Journal:  Mol Neurobiol       Date:  2021-09-14       Impact factor: 5.590

Review 7.  Defective mitophagy in Alzheimer's disease.

Authors:  Jangampalli Adi Pradeepkiran; P Hemachandra Reddy
Journal:  Ageing Res Rev       Date:  2020-10-03       Impact factor: 10.895

Review 8.  Synaptic basis of Alzheimer's disease: Focus on synaptic amyloid beta, P-tau and mitochondria.

Authors:  Albin John; P Hemachandra Reddy
Journal:  Ageing Res Rev       Date:  2020-11-04       Impact factor: 10.895

9.  Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease.

Authors:  Arubala P Reddy; Xiangling Yin; Neha Sawant; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2021-05-29       Impact factor: 6.150

10.  Selective serotonin reuptake inhibitor citalopram ameliorates cognitive decline and protects against amyloid beta-induced mitochondrial dynamics, biogenesis, autophagy, mitophagy and synaptic toxicities in a mouse model of Alzheimer's disease.

Authors:  Arubala P Reddy; Neha Sawant; Hallie Morton; Sudhir Kshirsagar; Lloyd E Bunquin; Xiangling Yin; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2021-05-28       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.